Criterion 41 addresses the legal information a client needs before deciding whether to participate. The answer depends on the substance, the activity, the people involved, and the place where the service occurs. A local policy change may leave other restrictions in force, and permission for one activity may not extend to another. This module develops a method for checking the applicable rules and explaining their limits. It also examines medical staffing, travel, religious claims, research access, and personal questions that require qualified legal advice. The legal examples must be checked against current primary sources before they are used in practice.
Learning Objectives
By the end of this module, the trainee will be able to:
- Explain why legal education protects the client, the facilitator, and the program.
- Distinguish decriminalization, regulated access, and legalization, and explain why clients confuse them.
- Explain how federal, state, and local law interact, and why local measures do not override higher law.
- Separate authorization to provide a substance from authority to deliver medical care, and identify questions requiring clinical and legal review.
- Explain the different regulatory pathways relevant to ibogaine, ketamine, authorized research, and possible expanded access.
- State the scope boundary: facilitators educate on law and do not give legal advice.
- Explain the program's own legal boundaries clearly, including sourcing, handling, and take home rules.
- Recognize the transport and border hazard and communicate it explicitly.
- Surface a client's situation specific legal concerns and route them to qualified counsel.
- Verify current law from primary sources and keep legal knowledge current and dated.
- Convey legal reality in plain language, honestly, without jargon, intimidation, or false reassurance.
- Maintain current authorization documents and a usable register of reporting and record duties.
- Distinguish applicable law, clinical judgment, program policy, and research guidance.
Key Terms
Legal education. Informing a client accurately about the legal status of the substances and practices involved in their region, so they can make informed decisions and avoid unintended legal harm. Distinct from legal advice.
Individual legal advice. Advice about how the law applies to a particular person or arrangement. Refer questions requiring this interpretation to a qualified attorney in the relevant jurisdiction.
Decriminalization and enforcement priority. Changes that may reduce penalties, remove specified criminal offenses, or direct local enforcement resources. These measures have different legal effects, and their exact text must be checked.
Regulated access. A narrow, licensed legal channel through which a substance may be administered or received under specific conditions, such as state licensed supervised psilocybin service programs, with rules about who, where, and how.
Legalization. A change permitting specified conduct under law, often with conditions. The word alone does not identify which substances, activities, people, or locations are covered.
Layered jurisdiction. The reality that federal, state, and municipal law operate simultaneously. A city or state measure does not repeal federal law, and a client can be compliant at one level and exposed at another.
Program legal boundary. The explicit statement of what is legally sanctioned within a given program, including how medicine is sourced and handled and what a client may or may not do with it, particularly whether anything may be taken away.
Medical care requirements. The assessment, staffing, monitoring, equipment, and treatment capabilities needed for a proposed service. Their availability and legal authorization must be established for the actual setting and practitioner roles.
Clinical and substance authorization. The separate questions of what a clinician may do within professional scope and what authority permits possession, supply, or administration of the substance. The details of an arrangement require legal review; describing care as separable does not establish its legality.
Transport hazard. The specific and serious risk created when a client carries a controlled substance away from a legal or tolerated setting, across state lines or international borders, which can transform lawful participation into a serious offense.
Core Teaching
Checking the law that applies to the service
Begin with a written description of what the program intends to do. Identify the substance, how it will be obtained and stored, who will provide it, where the client will receive services, and what happens afterward. Check the governing statutes, regulations, licenses, and official program requirements for each activity. A facilitator can explain verified program information and help a client locate primary sources. Questions about an individual's exposure, or the legality of a proposed arrangement, belong with an attorney qualified in the relevant jurisdiction. Keep the source and date of each legal statement so staff can update the explanation when the rules change.
Understanding the scope of a reform
A measure described publicly as decriminalization may remove a penalty for specified conduct or may only change enforcement priority. A licensed access program may permit defined services at approved locations while leaving other possession or supply prohibited. Legalization can also be limited by age, quantity, location, or commercial restrictions. Ask what conduct the actual text permits and what remains restricted. Avoid treating these terms as a fixed ladder from illegal to legal. Explain the practical boundaries using the client's question, such as whether they can participate at a licensed site, possess a substance elsewhere, or take anything home.
National and local authority
In the United States, federal scheduling and state or local reforms can operate at the same time. A state program does not by itself remove federal controlled substance restrictions. Check the current federal schedule and the particular state authorization rather than relying on a program's marketing language. Ketamine has an established medical regulatory pathway, while the authority for other substances must be evaluated individually. Religious freedom protections are also specific to the legal claim, organization, conduct, and conditions involved. A religious description or a pending petition does not establish permission for a service. Have counsel review the actual authorization or court decision and explain its scope to the client.
Clinical care and authorization to administer a substance
A program needs to establish both the care the participant may require and the authority for the proposed service. A professional license does not authorize every controlled substance activity, and permission to facilitate a session does not grant competence to manage cardiac disease or prescribe medication. These questions should be reviewed together by qualified clinical leadership and counsel. The legal analysis can depend on federal and state rules, the precise conduct of each practitioner, the setting, and the terms of a research or other authorization. There is no general legal rule in this workbook by which the presence of a medical intervention automatically determines whether the entire arrangement is lawful.
Medication changes require individual clinical assessment. A facilitator should not direct a client to stop an antidepressant or other prescribed drug to become eligible for a session. A prescriber needs to consider the reason for treatment, withdrawal effects, relapse risk, interactions, and available alternatives. Similar planning applies to monitoring, emergency medicines, and management of comorbid conditions. Confirm who can perform each task and under what authority. If the necessary care cannot be provided in the proposed setting, do not proceed there. This decision concerns the program's actual capabilities and authorization; it should not become an unsupported claim that the client can obtain no lawful medical care anywhere.
Ketamine illustrates why the product, indication, and delivery model need separate explanation. Medical use of ketamine does not mean that every promoted psychiatric use, compounded product, or remote service has FDA approval or equivalent safeguards. Verify the specific product and indication, who is prescribing, what monitoring is provided, and how complications are handled. For an investigational product, authorized research is one possible pathway. FDA expanded access provides another potential route for certain serious conditions outside clinical trials, subject to eligibility, sponsor cooperation, regulatory review, and other applicable requirements. It is not guaranteed access, and controlled substance requirements still need to be satisfied (U.S. Food and Drug Administration, n.d.).
Ibogaine requires particular attention to cardiac risk and the clinical resources available. Screening, electrocardiographic assessment, medication review, appropriate monitoring, electrolyte assessment and management, and the ability to treat an emergency need qualified clinical leadership. A normal screening result cannot guarantee safety. The relevant concern is the actual protocol, staffing, and ability to respond throughout the period of risk. Separately, verify the authority for obtaining and administering ibogaine in the jurisdiction involved. A program should not represent possession reform, a clinical credential, or the availability of equipment as sufficient legal authorization. Criteria 1 and 2 provide the substance specific safety background (Koenig & Hilber, 2015).
Research funding and treatment availability are separate matters. Texas legislation supporting ibogaine research illustrates the need to read what a measure authorizes: funding a research program does not itself authorize ordinary clinical prescribing or remove federal requirements. A client considering a study needs information from the authorized research team about recruitment, eligibility, procedures, costs, and oversight. Personal possession reforms elsewhere also need to be read for their exact scope; they do not establish the medical readiness of a service. For a program abroad, verify local authorization, practitioner credentials, emergency transfer arrangements, and the care available after the client returns home. A country's reputation as a treatment destination cannot answer those questions for an individual facility.
Preliminary medical assessment, ongoing treatment by the client's prescriber, and emergency care can have purposes and legal bases distinct from administration of the psychedelic. Involve the client's established clinicians when they agree and when information sharing is authorized. Give them an accurate account of the proposed service and the question being asked. A request for “clearance” should state the relevant exposure and clinical concerns, rather than asking a physician to approve an unspecified retreat. A clinician's participation does not automatically endorse the program or transfer responsibility for its conduct.
For an arrangement involving clinical staff, obtain review of the actual duties, supervision, licensing, controlled substance rules, and professional liability coverage. Labeling someone an independent contractor or describing care as separate does not settle these questions. Likewise, it is inaccurate to say that any medical care delivered around an unlawful substance automatically voids a license or insurance policy. The terms and applicable law must be examined. In an emergency, activate qualified care promptly and describe the suspected exposure honestly. Legal uncertainty should not become a reason to delay help for a person who is unwell.
Questions requiring an attorney
Explain the verified rules governing the program and identify questions that require individual legal advice. These can include employment, professional licensing, custody, immigration, benefits, probation, or parole. Do not promise that participation will have no consequence in one of these areas. Ask whether the client would like help locating counsel with relevant experience, and allow time for that consultation before a decision. Staff should also recognize when they are being asked to interpret a contract, a court condition, or an exemption beyond their competence.
Explaining the program’s authorization
Give the client a clear account of the program's legal basis, the roles of its practitioners, and the boundaries of the service. Explain sourcing, handling, administration, and any restriction on possession or removal of a substance. Make the relevant documents available in a form the client can understand. If the authorization has limits or there is an unresolved question, state it explicitly and obtain the necessary review. Consent records should show what was explained and what questions remained. A client's signature does not cure an unauthorized practice or excuse misleading information.
Personal circumstances and legal questions
Invite clients to identify circumstances that may affect their decision, including a professional license, an immigration matter, a custody dispute, military or employment obligations, or court supervision. They need not disclose private details to receive the general information. Explain that the program cannot determine the consequences of their individual situation and offer an appropriate legal referral. Ask about the time needed to obtain advice and whether participation should be postponed while the question is resolved. An unanswered legal concern should remain visible in the plan.
Maintaining a local legal briefing
Keep a written briefing for the place where the service operates. Identify each activity separately: advertising, screening, storing a substance, transferring it, administering it, supervising use, providing healthcare, and offering follow up. Record the governing source, effective date, date checked, and the person responsible for keeping the entry current. A general statement that a city is tolerant of psychedelics cannot answer these separate questions.
Read the operative text and the regulator's current guidance. A press release may describe a proposal that has not taken effect, and an enacted law may require rules or licensing before a service can begin. Oregon Health Authority's administrative rules page, for example, distinguishes current rules from rulemaking activity. Save the version used for a decision and check whether an amendment has changed it. A proposed rule should not be presented to a client as an existing permission (Oregon Health Authority, n.d.).
Where the answer requires legal interpretation, give counsel the actual service description. Include who supplies or handles the substance, where participants and staff are located, what clinical care is offered, and which organizations contract with one another. Ask a defined question and record the advice in the appropriate administrative file. Do not repeat a lawyer's conclusion about one arrangement as permission for every superficially similar program.
Research access and ordinary service access
A research announcement does not establish access for the public. Check whether a study is recruiting, who is eligible, what participation involves, and how the study team can be contacted. Trial registration alone does not establish regulatory approval, safety, or effectiveness. A participant may be ineligible, receive a comparison intervention, or decide the demands of the protocol do not suit them.
FDA expanded access is a potential route to an investigational medical product outside a clinical trial for qualifying serious or immediately life threatening conditions when the relevant requirements are met. It requires appropriate medical and regulatory involvement; it is not a general exception for a facilitator to arrange psychedelic sessions. Product availability and controlled substance requirements still need consideration. Describe the route accurately without promising that a particular drug can be obtained through it.
Texas Senate Bill 2308, enacted in 2025, concerns a consortium and research program to support ibogaine drug development. Its provisions address clinical trials, clinical teams, cardiac safety, aftercare, and data integrity. Research legislation should be explained as research legislation. It does not by itself establish that an ordinary retreat may provide the same intervention or that a client has a place in a study (Texas Legislature, 2025).
Medical care and legal authorization
A need for clinical monitoring raises questions about the client's condition, the proposed intervention, staff qualifications, equipment, and access to emergency treatment. Have an appropriately qualified clinician determine the medical requirements. Have qualified counsel address the authority for the proposed activities. Calling care “separate” or “inseparable” from a session does not answer either inquiry by itself.
A clinician's professional license does not automatically authorize every use of a controlled substance. Equally, the presence of a prohibited substance does not make all medical care for the person unlawful. Keep emergency procedures explicit. Staff must seek appropriate help promptly and provide responders with relevant information. Concerns about reputation, licensing exposure, or the program's legal position must not delay emergency care.
Review insurance and contractual arrangements for the work actually being done. Ask the insurer or broker for a documented answer about the relevant activities and exclusions. A policy title, a practitioner's ordinary coverage, or the presence of a contracted medic cannot establish coverage for every event. Assign responsibility for reviewing changes in services before they are introduced.
Travel and remote services
Discuss travel before the client departs. Permission for an activity in one setting does not establish permission to possess or transport a substance elsewhere. Explain the program's rules for possession and removal, and direct individual transport, customs, or immigration questions to qualified counsel. Do not give methods for avoiding detection or assurances about enforcement.
For remote clinical services, the client's physical location may affect which professional rules apply. Confirm it at the encounter and verify the provider's authority for that location. A client traveling during follow up may need different arrangements. Religious claims require similar precision: membership in a church or use of religious language does not establish that a particular person's conduct is legally protected. Review the actual authority, its parties, conditions, and scope with counsel.
Translating program rules into ordinary situations
Work through the situations a client is likely to encounter. Can they bring a support person? Who may handle the substance? Can a session be moved to another location? What happens if they leave early? Which follow up services are available when they return home? Explain the program's verified rules using these examples and identify questions that need further review.
Keep the explanation consistent across the website, booking materials, consent documents, and staff conversations. A precise intake form is undermined by a salesperson promising exceptions. Give staff a shared current account and a way to escalate a question they cannot answer. When a rule changes, identify affected bookings and tell those clients what the change means for their arrangements.
Keeping the legal basis attached to the service
Maintain an administrative file containing the authority the program relies on for each activity. Record the legal entity, licensed location, responsible professionals, substances or services covered, effective dates, conditions, and renewal requirements. Keep the underlying documents available to the people who need them. A summary helps staff explain the service, but a summary alone cannot establish what a license, order, or authorization permits.
Assign review dates and triggers. A new location, different product, additional profession, remote client in another jurisdiction, or change in ownership can require another review. Before advertising or booking the changed service, obtain the necessary interpretation and update the client materials. Record who approved the operational change and which questions remain open. A permission attached to one organization or location should not silently migrate to another arrangement.
Separating a legal requirement from a program choice
Clients deserve to know the basis of a restriction. Some conditions come from law or the terms of an authorization. Others come from clinical judgment, insurance terms, or the program's own policy. State the actual basis and identify who can review it. Calling every program preference a legal requirement makes the explanation difficult to trust and prevents a useful discussion of alternatives.
For each local requirement, keep the official source and effective version. Staff can then answer a question about age, location, consent, record retention, or professional role from the provision that applies. If a policy is more restrictive than the law, explain the program's reason plainly. If the answer requires an attorney's interpretation, route the defined question and give the client a realistic date for an answer.
Making reporting obligations usable
The program needs a current list of reporting duties that apply to its work, with the event that triggers each duty, the responsible role, the receiving authority, and the applicable deadline. Include the required form or reporting route and who covers the task during absence. The details can differ for a licensed service, a clinical practice, and a research study. Use the rules governing the actual service when developing this list.
During an incident, immediate care proceeds while the responsible staff member determines and completes the required reports. Keep a record of submission and any follow up request. A report sent to an insurer, an internal incident log, and a report required by a regulator may serve different purposes. Completing one does not establish that all duties have been met. Privacy and legal staff should resolve uncertainty about disclosure promptly.
Records and rights across organizational boundaries
Explain who maintains the client's record when several organizations provide the service. The booking company, facilitator, clinic, laboratory, and referring practitioner may have different responsibilities. Record which entity holds each part, who can request access, and how information will move for care. Check contracts and applicable law before moving records to a new provider or another country.
Make a plan for closure, license surrender, and the departure of a practitioner. Name the records custodian and keep a client contact route available for the required period. A business ceasing to operate can leave clients needing copies for continuing care. Determine retention and transfer obligations in advance, including any preservation requirement arising from a complaint or legal matter. Explain the arrangements without promising that every record follows one universal rule.
Research guidance and clinical service requirements
The FDA's E6(R3) Good Clinical Practice guidance addresses clinical trials and the responsibilities of investigators and sponsors. It is a useful reference when designing traceable research records and assigning trial duties. Its publication does not authorize a retreat or turn routine client care into a clinical investigation (U.S. Food and Drug Administration, 2025). A program undertaking research needs the applicable ethical, regulatory, and institutional review before recruitment or research procedures begin.
Keep the research purpose separate in the documents clients receive. Identify which information is required for care, which collection belongs to a research protocol, and what choices the person has. Ask the appropriate research oversight body to determine requirements when the status of a proposed project is uncertain. Do not describe a program's own decision to call something quality improvement as proof that review is unnecessary.
Clinical and Decision Tools
Tool 1 Reading the scope of a legal reform
Check the conduct covered, conditions imposed, and authority whose rules remain in force.
Term | What to verify | Limits |
|---|---|---|
Decriminalization | The specific conduct and penalties changed by the measure | Does not necessarily create regulated supply or change other jurisdictions' laws |
Enforcement priority | Which agency's enforcement policy changed | A low priority policy is not a general authorization |
Regulated access | Eligibility, licensing, permitted activities, setting, and conditions | Permission applies within the actual scheme |
Legalization | The activities for which prohibition was removed | Other restrictions may remain; read the operative law |
Tool 2 Layered jurisdiction
Use primary sources to check each applicable level of law and record when it was reviewed.
Level | Review |
|---|---|
Local | The exact ordinance, resolution, or policy and the authority it changes |
State or regional | Statutes, current regulations, licensing, and program conditions |
Federal or national | Applicable controlled substance, healthcare, research, and other requirements |
Tool 3 Reviewing clinical needs and legal authorization
Confirm the required care, the program's capacity, the authority for each activity, and any unresolved question requiring counsel.
Question | Source of review | Action |
|---|---|---|
What medical care does this person need? | Appropriately qualified clinician | Identify assessment, monitoring, treatment, and emergency requirements |
Can the proposed setting meet those needs? | Responsible clinical and program leads | Confirm staff, equipment, availability, transfer, and follow up |
What activities are authorized? | Primary law, regulator, and qualified counsel | Verify the particular arrangement and its conditions |
Is any required element unresolved? | Responsible decision maker with appropriate consultation | Pause the affected service; seek appropriate care and clarification |
Tool 4 Clinical care questions in different settings
Use these examples to identify who needs to assess the clinical requirements and who needs to review the legal arrangement.
Situation | Medical question | Program response |
|---|---|---|
Ibogaine | Serious cardiac risks require specialist assessment of the intervention and setting | Verify clinical capability and legal authority; do not infer safety or access from research announcements |
Medication with an MAOI containing preparation | Interaction and any medication change require qualified review | Provide accurate information to the clinician; do not direct a taper outside scope |
Acute emergency | What urgent care is needed now? | Activate help promptly; follow training and emergency instructions |
Cardiac, seizure, or blood pressure history | How does the history affect the proposed intervention? | Obtain an appropriate assessment and confirm required capabilities |
Ketamine service | What assessment, administration, monitoring, and follow up are required? | Verify professional authority, medication rules, service standards, and individual suitability |
Tool 5 Program information and individual legal advice
Explain verified program requirements and refer questions about the client's individual legal position.
Education (in scope) | Legal advice (out of scope: refer to an attorney) |
|---|---|
Describing what the law provides and what this program permits | Applying the law to the client's specific situation |
Naming where risks lie and that an area is legally gray | Advising what the client should do about their exposure |
Directing clients to authoritative sources and counsel | Guaranteeing outcomes (no arrest, no custody loss, no license issue) |
Tool 6 Individual legal questions
Ask whether a category is relevant without requiring the client to disclose unnecessary personal details.
Client circumstance | Facilitator action |
|---|---|
Non citizen / immigration status | Raise; route to immigration counsel (consequences can be severe) |
Probation, parole, or court supervision | Raise; route to counsel; consequences can be immediate |
Licensed professional / safety sensitive job / drug testing | Raise; route to counsel or licensing board guidance |
Custody or family court matters | Raise; route to family law counsel |
Benefits eligibility (e.g., veterans) | Raise; route to qualified counsel or a benefits advisor |
Tool 7 Legal education checklist
Confirm the education was accurate, structural, current, plain, and in scope.
Check | Done? |
|---|---|
Actual local measure explained, including conduct and limits | Yes / No |
Relevant jurisdictions and program permissions identified | Yes / No |
Program rules provided clearly, including substance handling and removal | Yes / No |
Required clinical care, capability, and legal authority reviewed separately | Yes / No |
Possession and travel questions addressed through appropriate sources | Yes / No |
Individual exposure questions referred to qualified counsel | Yes / No |
No guarantee of legal, licensing, immigration, or employment outcomes | Yes / No |
Primary sources and verification dates recorded | Yes / No |
Unresolved questions assigned for review before affected services proceed | Yes / No |
Local legal and reporting register
Entry | Required detail | Responsible review |
|---|---|---|
Authority for the activity | Entity, location, activity, official source, effective version | Qualified legal or regulatory review |
Operating condition | What must be in place and the evidence of completion | Named program role and review date |
Reporting duty | Trigger, recipient, deadline, form or route | Assigned reporter and backup |
Records requirement | Type of record, access, retention, transfer and disposal | Records custodian with legal or privacy advice |
Change in service | Proposed change, affected documents and clients | Decision before the changed service begins |
Worked Example Explaining Legal Limits
This fictional example applies the practices discussed in this module.
Context: A client is preparing to participate. He mentions that his city decriminalized psilocybin, so he assumes he can now buy it, keep some at home, and bring some back from the program. He is also a nurse, and asks whether this will affect his license.
Checking the local measure: The facilitator asks which measure the client means and reviews its actual provisions. They explain which activities and penalties it changes, what restrictions remain, and what still needs legal clarification.
Jurisdiction: The facilitator explains that local, state, and federal rules may each apply. A local measure does not repeal federal law. They identify the sources governing this program and the date those sources were checked.
Program rules: The facilitator explains the program's verified permissions and restrictions, including how the substance is handled and whether any removal is permitted, and provides the relevant information in writing.
Travel: The facilitator explains that permission within the program does not establish permission for possession or transport elsewhere. The client's proposed purchase and travel plans require separate legal review.
Arranging legal advice: On the nursing license, the facilitator explains that an attorney familiar with professional licensing needs to review the client’s circumstances. They help him find qualified counsel and allow time for an answer before participation.
Honest about ambiguity: Where the client presses for certainty the facilitator does not have, the facilitator says plainly that the area is unsettled, explains what that means practically, and declines to offer a false assurance.
Case Vignettes
For each vignette, identify the concern, describe the response, and explain your reasoning. Record your responses on a separate page.
Vignette A
Clients finish a retreat abroad, and several put remaining medicine into their luggage to bring home, assuming that because the ceremony was permitted where they were, carrying some back is a minor matter. Nobody told them otherwise. One is detained at the border.
Guided questions: Identify the rules that need to be checked for the session and the travel route. Write the explanation the client should receive before departure.
Vignette B
A client says their city decriminalized psilocybin and concludes they can now legally buy it and keep it at home. The facilitator, not wanting to seem discouraging, nods along and does not correct the misunderstanding.
Guided questions: Which activities does the actual measure cover? What restrictions remain? How would you help the client verify their understanding?
Vignette C
A client with a professional license asks the facilitator whether participating will jeopardize it. The facilitator, wanting to be reassuring, tells them confidently that it will not be a problem and that nobody ever gets in trouble for this.
Guided questions: What scope line did the facilitator cross? Why is a guarantee particularly dangerous here? What is the correct handling of a situation specific legal question?
Vignette D
A facilitator explains the legal situation using information they learned three years ago and never rechecked, unaware that the relevant program rules and state law have changed materially since. The client acts on outdated information.
Guided questions: Why is currency a professional duty in this criterion? Where should the facilitator have verified the law? How should legal knowledge be dated and maintained?
Vignette E
A client who is not a citizen asks a general question about risk. The facilitator, unaware that immigration consequences in this area can be severe and unforgiving, gives a casual reassurance without ever raising immigration exposure as a distinct category.
Guided questions: Identify the personal legal question and the appropriate professional to address it. How will the program explain its limits and allow time for advice?
Vignette F
A client says they have read that their state decriminalized ibogaine and that another state is funding ibogaine trials, and concludes that ibogaine is becoming legal and that they can arrange a session domestically. The facilitator, unclear on the distinctions themselves, does not correct this.
Guided questions: What does the actual decriminalization measure cover? What does research funding authorize? Which medical, regulatory, and access questions need verification before discussing any particular ibogaine service?
Role Play and Practice Scripts
Practice with a partner or team, then exchange roles. Use fictional details and discuss the choices made in each response.
Correcting decriminalized means legal
Practice: “Let's check the measure you mean. We need to know which activities it covers, which restrictions remain, and whether it has taken effect. I can show you the program's rules; a question about your own legal exposure needs an attorney.”
Naming the transport hazard
Practice explaining the program's rule on removal and the need to check possession and transport laws separately. Say what is verified and refer individual travel or customs questions to counsel. Avoid guarantees about enforcement or the severity of every possible offense.
Telling the truth about ibogaine
Practice: “Ibogaine has serious cardiac risks, and a clinical team needs to assess the medical requirements. Research funding does not establish access to a treatment service. We also need to verify the authority for the particular program you are considering. I cannot establish its safety or legality from that announcement.”
Referring a legal question
Practice: “I cannot determine how participation would affect your custody case. An attorney familiar with the case and the relevant law can advise you. I can provide an accurate description of this program for that discussion.”
Admitting uncertainty honestly
Practice identifying the unresolved question, the source you will check, and who can interpret it. Give a realistic date for an update. Do not describe uncertainty as permission to proceed.
Additional Practice
A research announcement used as permission
A retreat cites a state research funding announcement and the presence of a licensed nurse as proof that its investigational treatment is authorized. A client asks whether they can take the substance home.
Practice questions: Identify the separate clinical, legal, and transport questions. List the primary documents and qualified reviewers needed. Draft a plain explanation of what remains unverified.
Applied Record Exercise
A new service at another location
A program plans to use its existing consent forms for a new location operated by another company. Staff assume the original authorization and record policy transfer with the facilitator.
Task: List the documents and activities requiring review, the responsible professionals, and the questions affecting booking, consent, reporting, and record custody.
Review: The trainee identifies the entity and location limits, distinguishes legal requirements from policy, and keeps unresolved authorization questions visible before the service is offered.
Self Assessment and Reflection
Knowledge check
Explain why legal education protects the client, the facilitator, and the program.
Distinguish decriminalization, regulated access, and legalization, and state what decriminalization typically does not do.
Explain layered jurisdiction and why a municipal measure does not confer the protection a client may assume.
State the scope boundary between legal education and legal advice, and give examples of each.
Explain how clinical requirements, setting capability, and legal authority are reviewed for a proposed service.
Use ibogaine and ketamine to identify the different questions about clinical risk, medication rules, and professional authority.
Explain the transport hazard and how it should be communicated.
Identify circumstances requiring individual legal advice and describe how to arrange an appropriate referral.
Explain how a facilitator should verify and maintain current legal knowledge.
Reflection
When did you last verify the law in your own region of practice, and from what source? Is your knowledge dated?
Where are you tempted to reassure a client about legal risk in order to relieve their anxiety? What would it cost them if you were wrong?
Do you have access to an attorney you could refer a client to? If not, how will you build that relationship before you need it?
Observed Practice Assessment
Provide the trainee with a fictional program authorization and a proposal to add a service at another location. Include a marketing statement that goes beyond the authorization.
The trainee identifies the authorized entity, activities, location, dates, and conditions; distinguishes legal requirements from organizational policy; and lists the questions requiring counsel. Their briefing identifies official sources, unresolved issues, the responsible reviewer, and what clients can accurately be told before booking.
Claiming that a professional license, research announcement, decriminalization measure, or religious description authorizes conduct without examining its scope requires correction before the briefing is used.
The assessor records the scenario, date, work reviewed, observed performance, feedback, and any required practice. Use the ratings demonstrated, needs further practice, or not observed for each task. A verbal answer alone cannot establish performance on a task requiring demonstration. Confirm readiness only for the work assessed and within the trainee’s authorized role.
Summary
Legal education requires current, specific information about the activities and jurisdictions involved. Explain the actual measure or regulatory scheme and the program’s permissions and restrictions. Verify clinical requirements, service capability, and legal authority through the appropriate professionals. Research funding, trial registration, professional credentials, and religious claims each require their own examination. Discuss possession and transport separately from participation in a setting. Individual questions about immigration, custody, employment, benefits, or licensing belong with qualified counsel. Keep sources and verification dates, assign unresolved questions, and update clients when an answer changes. Emergency care must remain promptly accessible.
References
Koenig, X., & Hilber, K. (2015). The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation. Molecules, 20(2), 2208-2228. https://doi.org/10.3390/molecules20022208
Oregon Health Authority. (n.d.). Oregon Psilocybin Services: Administrative rules and rulemaking process. Retrieved September 18, 2026, from https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/Pages/Psilocybin-Administrative-Rules.aspx
Texas Legislature. (2025). Senate Bill 2308, 89th Legislature, Regular Session (enrolled text). https://capitol.texas.gov/tlodocs/89R/billtext/html/SB02308F.htm
U.S. Food and Drug Administration. (2025, September). E6(R3) good clinical practice (GCP): Guidance for industry. https://www.fda.gov/media/169090/download
U.S. Food and Drug Administration. (n.d.). Expanded access. Retrieved September 18, 2026, from https://www.fda.gov/news-events/public-health-focus/expanded-access

